WASHINGTON, Oct 14 (Reuters) - U.S. Democratic lawmakers are expanding a probe into direct-to-consumer drug advertisements to include Bayer AG's combination aspirin product, according to letters ...
Pharma sales growth, new drug approvals and faster-than-expected asset sales may show the bright side of today’s Bayer. But mounting Roundup lawsuits are a darker story. The number of plaintiffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback